New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine

M. V. Relling; R. M. Krauss; D. M. Roden; T. E. Klein; D. M. Fowler; N. Terada; L. Lin; M. Riel-Mehan; T. P. Do; M. Kubo; S. W. Yee; G. T. Johnson; K. M. Giacomini

doi:10.1002/cpt.755

New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine

M. V. Relling
, R. M. Krauss
, D. M. Roden
, T. E. Klein
, D. M. Fowler
, N. Terada
, L. Lin
, M. Riel-Mehan
, T. P. Do
, M. Kubo
, S. W. Yee
, G. T. Johnson
, K. M. Giacomini

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

33 被引用数 (Scopus)

抄録

The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.

本文言語	英語
ページ（範囲）	897-902
ページ数	6
ジャーナル	Clinical Pharmacology and Therapeutics
巻	102
号	6
DOI	https://doi.org/10.1002/cpt.755
出版ステータス	出版済み - 12-2017
外部発表	はい

All Science Journal Classification (ASJC) codes

薬理学
薬理学（医学）

文献へのアクセス

10.1002/cpt.755

他のファイルとリンク

引用スタイル

Relling, M. V., Krauss, R. M., Roden, D. M., Klein, T. E., Fowler, D. M., Terada, N., Lin, L., Riel-Mehan, M., Do, T. P., Kubo, M., Yee, S. W., Johnson, G. T., & Giacomini, K. M. (2017). New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine. Clinical Pharmacology and Therapeutics, 102(6), 897-902. https://doi.org/10.1002/cpt.755

@article{eabc9ea48c174d33bed08f11ffe87eb9,

title = "New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine",

abstract = "The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.",

author = "Relling, \{M. V.\} and Krauss, \{R. M.\} and Roden, \{D. M.\} and Klein, \{T. E.\} and Fowler, \{D. M.\} and N. Terada and L. Lin and M. Riel-Mehan and Do, \{T. P.\} and M. Kubo and Yee, \{S. W.\} and Johnson, \{G. T.\} and Giacomini, \{K. M.\}",

note = "Publisher Copyright: {\textcopyright} 2017 American Society for Clinical Pharmacology and Therapeutics.",

year = "2017",

month = dec,

doi = "10.1002/cpt.755",

language = "English",

volume = "102",

pages = "897--902",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "6",

}

Relling, MV, Krauss, RM, Roden, DM, Klein, TE, Fowler, DM, Terada, N, Lin, L, Riel-Mehan, M, Do, TP, Kubo, M, Yee, SW, Johnson, GT & Giacomini, KM 2017, 'New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine', Clinical Pharmacology and Therapeutics, vol. 102, no. 6, pp. 897-902. https://doi.org/10.1002/cpt.755

TY - JOUR

T1 - New Pharmacogenomics Research Network

T2 - An Open Community Catalyzing Research and Translation in Precision Medicine

AU - Relling, M. V.

AU - Krauss, R. M.

AU - Roden, D. M.

AU - Klein, T. E.

AU - Fowler, D. M.

AU - Terada, N.

AU - Lin, L.

AU - Riel-Mehan, M.

AU - Do, T. P.

AU - Kubo, M.

AU - Yee, S. W.

AU - Johnson, G. T.

AU - Giacomini, K. M.

PY - 2017/12

Y1 - 2017/12

N2 - The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.

AB - The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.

UR - https://www.scopus.com/pages/publications/85033374059

UR - https://www.scopus.com/pages/publications/85033374059#tab=citedBy

U2 - 10.1002/cpt.755

DO - 10.1002/cpt.755

M3 - Comment/debate

C2 - 28795399

AN - SCOPUS:85033374059

SN - 0009-9236

VL - 102

SP - 897

EP - 902

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 6

ER -

New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine

抄録

All Science Journal Classification (ASJC) codes

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル